企業プロフィール
Cidara Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- CDTX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for CDTX.
企業概要
事業概要
Cidara Therapeutics is an anti-infective and immunotherapy company focused on drug-conjugate and engineered-therapy approaches. Its platform is aimed at serious infectious disease and immune-mediated conditions.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Cidara sits in specialty biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, platform validation, and the ability to create a differentiated anti-infective franchise.
バイオ業界での位置付け
Cidara is a catalyst-sensitive anti-infective name with meaningful dependence on program progress.
今後のカタリスト
- Cidara’s catalysts are CD388 and the broader antiviral/immunology platform, where the market will watch for development steps that show the lead asset can keep advancing. The company still needs clinical validation to keep the thesis strong.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。